Stock TUB FINANCIÈRE DE TUBIZE S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financière de Tubize S.A. Stock

Equities

TUB

BE0003823409

Pharmaceuticals

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:09 2024-05-27 am EDT 		5-day change 1st Jan Change
98.9 EUR -0.90% Intraday chart for Financière de Tubize S.A. +1.23% +37.94%
Mar. 27 Financière de Tubize SA Announces Board Resignations CI
Mar. 16 Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024 CI

Financials

Sales 2022 0.01 0.01 Sales 2023 - Capitalization 3.19B 2.93B
Net income 2022 85M 78.16M Net income 2023 88M 80.92M EV / Sales 2022 392,371,878,420 x
Net Debt 2022 46.73M 42.97M Net Debt 2023 78.63M 72.3M EV / Sales 2023 -
P/E ratio 2022
37 x
P/E ratio 2023
36.2 x
Employees 3
Yield 2022
1.21%
Yield 2023
1.35%
Free-Float 33.86%
More Fundamentals * Assessed data

Chart Financière de Tubize S.A.

Dynamic Chart

Latest news about Financière de Tubize S.A.

Financière de Tubize SA Announces Board Resignations CI
Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024 CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Financière de Tubize SA Announces Dividend Approval, Payable as from 5 May 2023 CI
Financière de Tubize SA's Equity Buyback announced on December 1, 2018, has expired. CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Financière De Tubize SA Proposes Dividend, Payable on 5 May 2023 CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Financière de Tubize SA Approves Distribution of Gross Dividend for the Year Ended December 31, 2021, Payable on 5 May 2022 CI
Financière de Tubize SA to Consider the Resignation of Edouard Janssenas as Director CI
Financière De Tubize Sa Proposes Dividend for 2021, Payable on 5 May 2022 CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Financière De Tubize Sa Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Financière de Tubize SA Approves Dividend, Payable on May 6, 2021 CI
More news

Press releases Financière de Tubize S.A.

Financiere de Tubize S A : Half-year financial report 2022 PU
Financiere de Tubize S A : Annual financial report 2021 PU
Financiere de Tubize S A : Half-year financial report 2021 PU
Financiere de Tubize S A : Approval of the dividend PU
Financiere de Tubize : Buy-back of own shares PU
More press releases

News in other languages on Financière de Tubize S.A.

CORRECTIE : Degroof Petercam verhoogt koersdoel Tubize
Argenx en nieuwkomers zorgen voor rood slot Bel20
Pas op de plaats voor Bel20 ondanks koerswinst UCB
Degroof Petercam verhoogt koersdoel Tubize licht
Degroof Petercam schrapt GBL en Ackermans van kooplijst
More news

Quotes and Performance

1 day-0.90%
1 week+1.23%
Current month+1.75%
1 month+4.55%
3 months+25.03%
6 months+49.17%
Current year+37.94%
More quotes

Highs and lows

1 week
97.70
Extreme 97.7
101.00
1 month
93.20
Extreme 93.2
101.00
Current year
71.70
Extreme 71.7
101.00
1 year
60.80
Extreme 60.8
101.00
3 years
60.80
Extreme 60.8
101.00
5 years
49.80
Extreme 49.8
101.00
10 years
48.05
Extreme 48.045
101.00
More quotes

Managers and Directors - Financière de Tubize S.A.

Members of the board TitleAgeSince
Baron Daniel Janssen BRD
 Director/Board Member - -
Evelyn du Monceau BRD
 Director/Board Member 74 81-12-31
Cyril Janssen BRD
 Director/Board Member 53 07-12-31
More insiders

Quotes

Date Price Change Volume
24-05-27 98.9 -0.90% 5,624
24-05-24 99.8 -1.19% 11,297
24-05-23 101 +3.27% 38,724
24-05-22 97.8 -0.61% 12,471
24-05-21 98.4 +0.72% 29,172

Real-time Euronext Bruxelles, May 27, 2024 at 11:35 am EDT

More quotes

Company Profile

Financière de Tubize S.A. is a holding company that owns 36.24% of the listed biopharmacy group UCB.
Sector
Pharmaceuticals
Calendar
2024-07-24 - Q2 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
98.9 EUR
Average target price
134.8 EUR
Spread / Average Target
+36.25%
Consensus

Sector Other Pharmaceuticals

1st Jan change Capi.
FINANCIÈRE DE TUBIZE S.A. Stock Financière de Tubize S.A.
+37.94% 4.78B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.51% 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.74% 594B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.23% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.78% 328B
ABBVIE INC. Stock AbbVie Inc.
+1.35% 277B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 243B
NOVARTIS AG Stock Novartis AG
+8.44% 205B
ROCHE HOLDING AG Stock Roche Holding AG
-5.97% 203B
AMGEN INC. Stock Amgen Inc.
+6.19% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. TUB Stock